LEADER 07527nam 2202401z- 450 001 9910557632603321 005 20231214133047.0 035 $a(CKB)5400000000045088 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/69054 035 $a(EXLCZ)995400000000045088 100 $a20202105d2020 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aRecent Advances and Clinical Outcomes of Kidney Transplantation 210 $aBasel, Switzerland$cMDPI - Multidisciplinary Digital Publishing Institute$d2020 215 $a1 electronic resource (342 p.) 311 $a3-03936-364-6 311 $a3-03936-365-4 330 $aAdvances in immunosuppression and kidney transplant techniques have led to significant improvements in the short-term survival of the renal allograft. Long-term graft survival, however, has relatively lagged behind and has now become one of the main problems in kidney transplantation. In this Special Issue, we discuss the recent research developments in kidney transplants that may affect long-term allografts, as well as the survival of the patient. The latest developments in living kidney donation are also explored. 606 $aMedicine$2bicssc 610 $amalondialdehyde 610 $aoxidative stress 610 $anew-onset diabetes 610 $arenal transplantation 610 $aBK virus 610 $aBK virus nephropathy 610 $akidney allograft 610 $atransplantation 610 $aAlport syndrome 610 $achildren 610 $aautosomal dominant polycystic kidney disease 610 $aepidemiology 610 $ahospitalization 610 $akidney transplantation 610 $asubarachnoid hemorrhage 610 $amalignancy 610 $apost-transplant malignancy 610 $arenal cell carcinoma 610 $ameta-analysis 610 $asystematic reviews 610 $atacrolimus 610 $aC/D-ratio 610 $apharmacokinetics 610 $aopportunistic infection 610 $aallograft survival 610 $aurological complications 610 $aureteric stent 610 $aurinary tract infection 610 $atiming of removal 610 $aliving donor 610 $aethnicity 610 $aage 610 $aobesity 610 $agenetic relationship donor/recipient 610 $aatypical hemolytic uremic syndrome 610 $aeculizumab 610 $aglucose intolerance 610 $ainsulin secretion 610 $ainsulin resistance 610 $aoral glucose tolerance test 610 $ahealthy subject 610 $ahyperchloremia 610 $akidney graft dysfunction 610 $aliving donor kidney transplantation 610 $aUropathogenic E. coli 610 $aUPEC 610 $aphylogeny 610 $agenomics 610 $aantibiotic resistance 610 $avirulence traits 610 $anight-time renal transplantation 610 $agraft survival 610 $apatient survival/outcome 610 $asurgical complications 610 $aacute rejection 610 $alymphocyte 610 $aCD45RC 610 $aBelatacept 610 $acardiovascular high risk 610 $aoutcome 610 $amachine perfusion 610 $aorgan preservation 610 $atemperature 610 $ahypothermic 610 $anormothermic 610 $atransplant 610 $aproton-pump inhibitors 610 $airon 610 $airon deficiency 610 $apolyomavirus 610 $aBKV 610 $akidney 610 $aglomerulus 610 $aBKVAN 610 $anephropathy 610 $afluid management 610 $adelayed graft function 610 $agoal-directed fluid therapy 610 $acalcineurin inhibitor nephrotoxcity 610 $aC/D ratio 610 $atacrolimus metabolism 610 $aADPKD 610 $anative nephrectomy 610 $apatient outcome 610 $aperioperative complications 610 $aepidermal growth factor 610 $acreatinine 610 $agraft failure 610 $arenal transplantation. 610 $anew onset diabetes after renal transplantation 610 $asingle nucleotide polymorphisms 610 $aurinary biomarkers 610 $a?-GST 610 $a?-GST 610 $anephrotoxicity 610 $aurinary excretion of N1-methylnicotinamide 610 $amortality 610 $aniacin status 610 $adietary intake 610 $atryptophan 610 $avitamin B3 610 $aKidney transplant 610 $avitamin C 610 $acancer mortality 610 $aoxidative stress. 610 $amycophenolic acid 610 $aimmunosuppression 610 $aplasmapheresis 610 $aoxalate 610 $ahyperoxaluria 610 $akidney transplant recipients 610 $apost-transplantation diabetes mellitus 610 $aall-cause mortality 610 $acardiovascular mortality 610 $ainfectious mortality 610 $amagnesium 610 $ahypomagnesaemia 610 $acancer 610 $akidney transplant 610 $asurvival 610 $aliving kidney donation 610 $aliving-donor kidney transplantation 610 $abeliefs 610 $ainequity 610 $aischemia reperfusion injury 610 $ainnate immune system 610 $aadaptive immune system 610 $aapoptosis 610 $anecrosis 610 $ahypoxic inducible factor 610 $aendothelial dysfunction 610 $aproton pump inhibitor 610 $atransplant rejection 610 $aGFR 610 $ainsulin-like growth factor 1 610 $agrowth hormone 610 $amuscle mass 610 $apatient survival 610 $aphysical activity 610 $arenal transplant recipients 610 $akidney transplant (KT) 610 $adonor-specific antibodies (DSA) 610 $aC3d-binding assay 610 $aantibody-mediated rejection (AMR) 610 $aarsenic 610 $adiet 610 $afish consumption 610 $apost-transplant diabetes mellitus 610 $aN1-methyl-2-pyridone-5-carboxamide 610 $aN1-methylnicotinamide 610 $aurinary excretion 610 $akidney function 610 $abiomarker 610 $abranched chain amino acids 610 $aposttransplant diarrhea 610 $amethanogenesis 610 $aMethanosphaera stadtmanae 610 $amucins 610 $asulfate-reducing bacteria 610 $aacute humoral rejection 610 $afirst-line therapy 610 $aoutcomes 610 $aproteasome inhibitor 610 $arenal transplant 610 $atransplant recipients 610 $acalcineurin inhibitors 610 $aFK506 610 $apharmacokinetic 610 $afast tacrolimus metabolizers 615 7$aMedicine 700 $aCheungpasitporn$b Wisit$4edt$01277893 702 $aThongprayoon$b Charat$4edt 702 $aLeeaphorn$b Napat$4edt 702 $aCheungpasitporn$b Wisit$4oth 702 $aThongprayoon$b Charat$4oth 702 $aLeeaphorn$b Napat$4oth 906 $aBOOK 912 $a9910557632603321 996 $aRecent Advances and Clinical Outcomes of Kidney Transplantation$93012222 997 $aUNINA